Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
CNS Pharmaceuticals, Inc. (CNSP) had Normalized Pre-Tax Income of $-3.22M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-3.22M |
|
-- |
|
-- |
|
$3.25M |
|
$-3.25M |
|
$0.03M |
|
$-3.22M |
|
|
Normalized Pre-Tax Income |
$-3.22M |
$-3.22M |
|
$-3.22M |
|
$-3.22M |
|
$-3.22M |
|
$-3.25M |
|
$-3.25M |
|
0.56M |
|
0.56M |
|
$-5.76 |
|
$-5.76 |
|
| Balance Sheet Financials | |
$11.39M |
|
$0.00M |
|
$0.48M |
|
$11.87M |
|
$1.96M |
|
-- |
|
-- |
|
$1.96M |
|
$9.91M |
|
$9.91M |
|
$9.91M |
|
0.57M |
|
| Cash Flow Statement Financials | |
$-10.76M |
|
-- |
|
$14.16M |
|
$6.46M |
|
$9.86M |
|
$3.40M |
|
$0.10M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.81 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.76M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-32.48% |
|
-32.48% |
|
-27.12% |
|
-32.48% |
|
$17.23 |
|
$-19.25 |
|
$-19.25 |
|